🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and customer regulations, potentially leading to fines, prosecution or prison.

Service Reaction and Material Elimination

Based on the social media company, the service has taken down problematic content and banned related keywords and query recommendations. The company said it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.

Within minutes of entering one group, a seller shared WhatsApp details, where most purchases occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Item Details and Pricing

Within these communities, posts display black plastic packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to possibly significant medical dangers”.